Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 5 studies | 42% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| muscle | 100% | 10387.94 | 803 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 10850.98 | 856 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 36% | 2.73 | 29 / 80 |
| blood vessel | 29% | 115.21 | 381 / 1335 | 0% | 0 | 0 / 0 |
| brain | 18% | 46.50 | 476 / 2642 | 6% | 0.10 | 39 / 705 |
| adipose | 12% | 35.44 | 142 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 5% | 36.27 | 12 / 245 | 5% | 0.33 | 26 / 502 |
| breast | 4% | 13.89 | 18 / 459 | 1% | 0.04 | 6 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.25 | 2 / 45 |
| spleen | 4% | 5.39 | 9 / 241 | 0% | 0 | 0 / 0 |
| ovary | 3% | 7.33 | 6 / 180 | 0% | 0 | 0 / 430 |
| skin | 2% | 5.62 | 40 / 1809 | 1% | 0.03 | 5 / 472 |
| uterus | 2% | 2.14 | 3 / 170 | 1% | 0.05 | 6 / 459 |
| esophagus | 2% | 5.66 | 35 / 1445 | 1% | 0.02 | 1 / 183 |
| peripheral blood | 3% | 6.00 | 26 / 929 | 0% | 0 | 0 / 0 |
| lung | 2% | 16.54 | 10 / 578 | 1% | 0.04 | 12 / 1155 |
| adrenal gland | 0% | 1.67 | 1 / 258 | 2% | 0.03 | 4 / 230 |
| kidney | 0% | 0 | 0 / 89 | 2% | 0.06 | 19 / 901 |
| thymus | 1% | 6.68 | 9 / 653 | 0% | 0.01 | 3 / 605 |
| bladder | 0% | 0 | 0 / 21 | 1% | 0.15 | 7 / 504 |
| intestine | 1% | 0.75 | 5 / 966 | 0% | 0.01 | 2 / 527 |
| stomach | 0% | 0 | 0 / 359 | 1% | 0.09 | 2 / 286 |
| pancreas | 0% | 0 | 0 / 328 | 1% | 0.01 | 1 / 178 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.15 | 2 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042692 | Biological process | muscle cell differentiation |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | FBXO40 |
| Protein name | Alternative protein FBXO40 F-box only protein 40 (Muscle disease-related protein) |
| Synonyms | KIAA1195 FBX40 |
| Description | FUNCTION: Probable substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex that may function in myogenesis. . |
| Accessions | L8ECG7 ENST00000338040.6 Q9UH90 |